National pediatric professional membership organization and 501(c)(3) public charity
One uniform surface for comparison; detailed evidence is below.
The score summarizes assessed evidence; evidence coverage is reported separately.
Audited accounting categories. They do not identify the mutually exclusive ultimate payer classes behind grants, dues, subscriptions, education, advertising, and other revenue.
| Accounting category | Amount | Share |
|---|---|---|
| Contributions and grants | $48.38M | 35.33% |
| Membership dues | $25.79M | 18.84% |
| Subscriptions | $18.14M | 13.25% |
| Continuing education | $12.82M | 9.36% |
| Manuals and publications | $9.44M | 6.89% |
| National Conference and meetings | $7.80M | 5.70% |
| Advertising | $6.35M | 4.64% |
| Royalties | $3.82M | 2.79% |
| Investment income | $2.18M | 1.59% |
| Other income | $2.22M | 1.62% |
| Total | $136.93M | 100.00% |
Primary constituency: Pediatricians and pediatric specialists, with trainee and other pediatric professional categories; it is not a physician-wide representative body.
Physician alignment: Supportive for pediatrician members; not direct representation for family physicians or other non-pediatric clinicians.
Funding model: Diversified across grants, dues, publishing, education, meetings, advertising, royalties, and investments; ultimate payer concentration is indeterminate.
Primary influence: Elected physician Board formally; CEO and senior leadership operationally; grantors, publishers, enterprise members, and corporate partners have documented financial relationships without a disclosed dominant payer.
The American Academy of Pediatrics is a physician-member pediatric organization and public charity with approximately 67,000 pediatrician members. Its audited FY2025 statements report $136.93 million in revenue and support, led by contributions and grants, membership dues, subscriptions, and continuing education. The Board is physician-led and the operational team is identifiable. AAP’s education, clinical guidance, payment and coverage advocacy, and child-health work substantially track its mission. The principal accountability limitation is payer identity: public records do not reconcile individual, employer, government, foundation, hospital, and corporate support into mutually exclusive classes, and enterprise-paid membership is not quantified. The B grade is favorable for evidence and accountability, but it should not be read as evidence that AAP directly represents physicians outside pediatrics.
One sentence: AAP is a well-documented, physician-governed pediatric organization with strong mission alignment, but it is not a physician-wide representative and its ultimate payer mix remains indeterminate.
Every organization uses the same twelve evidence sections and order.
Illinois-headquartered nonprofit; IRS 501(c)(3), tax exempt since 1937. [4]
Optimal physical, mental, and social health for infants through young adults; support members’ professional needs. [5]
Approximately 67,000 pediatrician members. [5]
| Layer | Evidence-based conclusion |
|---|---|
| Formal constituency | Eligible individual pediatric physician categories hold voting rights; national officers must be Fellows or Specialty Fellows. [8] |
| Paying constituency | Dues may be individually or enterprise paid; grants, publishing, subscriptions, education, advertising, royalties, and other revenue also support AAP. The payer split is unknown. |
| Operational constituency | Programs and advocacy focus on child health and the profession of pediatrics, with board and executive priority-setting. |
| Beneficiaries | Children, families, pediatric clinicians, trainees, and systems that use AAP guidance and programs. |
| Reach | Broader clinicians and institutions may use AAP standards, but reach does not confer voting rights or establish representation. |
Source: current board page. [6]
Source: current senior leadership page. [7]
The board page states that AAP is governed by 13 directors plus the executive committee for 17 total positions; 10 district chairs are regionally elected and at-large members are elected nationally. The bylaws place the organization’s property, business, and affairs under the board and make the CEO responsible for day-to-day administration. [6][8]
The FY2025 Form 990 reports Mark Del Monte’s reportable compensation as $716,711 plus $17,786 in other compensation. Compensation is evidence of operational importance, not evidence of misconduct. [4]
The audited FY2025 statements report $136.93 million in revenue and support, $138.88 million in expense, a $1.95 million operating decrease, $6.35 million in realized and unrealized investment gains, and $92.81 million in ending net assets. [2]
Contributions and grants, 35.3%.
Dues, 18.8%.
Advertising plus royalties; payer identities not shown.
The Form 990 reports $138.50 million in revenue and $139.09 million in expenses. Those tax-return totals differ from the audited statement of activities because the reports use different presentation and tax-accounting rules; this review does not merge them. [4]
| Function | FY2025 expense | Share |
|---|---|---|
| Program services | $113,753,223 | 81.9% |
| Management and general | $21,942,496 | 15.8% |
| Fundraising | $3,182,015 | 2.3% |
| Total | $138,877,734 | 100.0% |
Not determinable.
Not determinable.
Not evaluable on a reconciled basis.
This uncertainty is why “Funding Independence and Concentration Risk” is marked NE rather than assigned a low score solely for nondisclosure.
The 2020 bylaws require chapters to be incorporated in their state or territory and to adopt compatible bylaws. Enterprise membership is described as a collaboration among national AAP, state chapters, and the participating pediatric organization. [8][10]
| Entity or channel | Relationship | Money-flow conclusion |
|---|---|---|
| National AAP | Subject of the audited financial statements and Form 990 reviewed here. | Financial conclusions in this report apply to the national organization unless stated otherwise. |
| State/territorial chapters | Separately incorporated; governance and finances are not automatically consolidated. | A complete national-to-chapter transfer table was not found. |
| Enterprise member organizations | Hospitals, academic programs, networks, associations, and other eligible groups can receive one invoice. | Organization-paid dues are documented as possible, but the national dollar total is unknown. |
| Friends of Children Fund / sponsorship channels | AAP fundraising and collaboration programs. | Named tiers exist; exact aggregate and project mapping are incomplete. |
| Actor | Evidence class | Documented channel | What is not established |
|---|---|---|---|
| Voting physician members | Direct | Elections, bylaws amendments, leadership forum, sections/councils. | Actual participation and influence by segment. |
| Board and executive committee | Direct | Governance, policy approval, executive oversight. | Public meeting-level voting records. |
| CEO and senior staff | Direct | Day-to-day management, advocacy, finance, law, education, medical and publishing operations. | Internal decision weighting by department. |
| Federal agencies | Direct relationship | Federal awards and project oversight. | Control of AAP-wide policy; 2025–26 litigation shows both dependence and disagreement. |
| Corporate supporters | Direct relationship | Tiered contributions, sponsorship, education/campaign collaboration. | Policy control or improper influence; no reliable evidence establishes it. |
| Enterprise organizations | Direct relationship | Group invoice, discounts, organization benefits. | Voting control or national policy control. |
| Dominant financial actor | Unknown | No reconciled payer table. | Top-one and top-three concentration. |
| Stated commitment | Relevant action or omission | Assessment | Confidence |
|---|---|---|---|
| Advance child health and support members | $113.75M program expense, including $48.84M child-health activities, $34.38M educational publishing, $16.05M education, $6.64M advocacy, and $3.90M research. | Aligned | High |
| Support pediatric professional needs | Membership, continuing education, clinical policy, payer advocacy, workforce and wellbeing initiatives. | Aligned | High |
| Evidence-driven, rigorously reviewed policy | Intent, evidence review, peer review, executive review, board vote, five-year cycle, author disclosures. | Supported | Moderate-high |
| Full independence from financial supporters | AAP states sponsors do not influence content or leadership and publishes some tiers and conflict processes. | Partially assessable | Moderate |
| Member governance | Voting rights and elections exist; 2025 turnout was 10.7%, and current public bylaws are old. | Aligned with limitations | Moderate |
Sources: financials [2], mission [5], policy process [14], supporters [12], conflicts [15], election [11].
| Issue | Affected segment | Label | Strongest support | Contrary fact / limitation | Confidence | Sources |
|---|---|---|---|---|---|---|
| Clinical guidance and education | Pediatricians and pediatric teams | Supportive | Extensive policy, journals, education, and quality programs. | Reach and output are not equivalent to independent outcome proof. | High | [5] [14] |
| Payment and coverage | Primary care, subspecialists, surgeons | Supportive | Dedicated payer committee and Medicaid/CHIP advocacy. | No comprehensive payment-win or practice-margin dashboard. | High | [16] [17] |
| Professional voice and autonomy | Pediatricians | Supportive | Member governance, policy participation, public advocacy, and litigation defending speech. | Institutional adoption of AAP policy may affect clinicians who did not participate. | Moderate | [6] [8] [18] [20] |
| Independent-practice viability | Independent pediatricians | Mixed | Payment and contract support. | No segment outcome data; enterprise relationships favor scalable group participation. | Moderate | [10] [16] |
| Administrative burden | All pediatric physicians | Not demonstrated | Practice and payer resources exist. | No current quantified burden-reduction outcome found. | Low | [16] |
| Employment mobility / noncompetes | Employed pediatricians | Unknown | No material current evidence located in reviewed governance, membership, or advocacy sources. | Insufficient public evidence. | Low | [5] [8] [16] |
| Rural and underserved care | Rural/community pediatricians | Supportive | Federal programs and advocacy include rural pediatric capacity. | Long-term outcomes and rural member influence not broken out. | Moderate | [3] [17] |
| Scope and professional representation | Family physicians and other non-pediatric clinicians | Potential conflict | AAP states pediatricians and pediatric specialists are best qualified for child health care. | AAP resources may still benefit broader clinicians; scope tension does not imply hostility. | High | [5] [9] |
| Patient care and public health | Children, families, pediatric clinicians | Supportive | Mission, spending, policy and public programs are child-health centered. | Some policy positions are politically and clinically contested. | High | [2] [5] [14] |
| Matter | Status as of July 24, 2026 | Evidence-calibrated conclusion | Mission relevance |
|---|---|---|---|
| FY2025 financial and federal-program audit | Final audit | Unmodified opinion; no material weaknesses, significant deficiencies, material noncompliance, financial-statement findings, or federal-program findings reported. [3] | Favorable current compliance evidence. |
| DOJ PedJobs settlement | Settled May 31, 2011 | AAP agreed to pay $22,000 to resolve allegations that job postings impermissibly limited applications by citizenship status. The release does not establish a current practice. [21] | Relevant to employment-platform oversight and historical remediation. |
| AAP v. HHS, No. 1:25-cv-04505 | Pending; case stayed | AAP, as plaintiff, obtained a preliminary injunction restoring nearly $12M in terminated grants; the case is stayed through Sept. 30, 2026, with a later status report due. No final merits judgment. [18][19] | Shows both advocacy independence and material federal-program dependence. |
| Florida enforcement action / AAP v. Uthmeier, No. 26-2238 | Pending en banc appeal | Florida alleges deceptive practices, RICO, and antitrust violations related to gender-affirming-care advocacy. A federal district court enjoined the action; on July 8, 2026, the Seventh Circuit granted en banc reconsideration, vacated the panel opinion, stayed the preliminary injunction pending appeal, and ordered the appeal heard initially en banc. The allegations are not adjudicated findings. [20] | Material to policy-process scrutiny, speech, and legal risk; clinical merits are outside this institutional review. |
Scores follow the Blair Compass evidence-and-accountability rubric. Letter grades are normalized to each dimension’s available points. A dimension is marked NE when missing evidence prevents a fair assessment of the underlying conduct; it is not assigned a low score merely because disclosure is incomplete.
| Dimension | Score | Grade | Confidence | Conclusion |
|---|---|---|---|---|
| 1. Financial Transparency and Source Identification | 13 / 15 | B | High | Current audited statements, a single audit, and a public Form 990 are readily available; ultimate payer identity remains incomplete. |
| 2. Funding Independence and Concentration Risk | NE | NE | Low | Not evaluable: public records do not provide a mutually exclusive ultimate-payer mix or top-funder concentration table. |
| 3. Mission-to-Action Alignment | 18 / 20 | A | High | Spending, policy production, education, advocacy, and child-health programming substantially track the stated mission. |
| 4. Physician or Member Governance and Representation | 12 / 15 | B | Moderate | Defined physician-member categories vote and elect leaders, while the board appoints and supervises the CEO. |
| 5. Breadth of Support Across Physician Segments | 7 / 10 | C | Moderate | AAP offers pathways for pediatric primary care, subspecialty, surgical, trainee, and other pediatric-team roles, but segment-level influence and outcomes are unevenly disclosed. |
| 6. Leadership, Conflict Management, and Accountability | 8 / 10 | B | Moderate | Current leaders, senior operational roles, compensation, and conflict-management processes are substantially visible. |
| 7. Legal, Regulatory, and Ethical Record | 9 / 10 | A | Moderate | The FY2025 audits reported no material weaknesses or federal-program findings; one older DOJ settlement and significant pending 2026 litigation require context. |
| 8. Outcomes and Public Accountability | 4 / 5 | B | Moderate | AAP publishes extensive policy, program, research, and financial information, but a unified independent outcomes dashboard was not found. |
| Overall | 71 / 85 supported; 84 / 100 normalized | B | Moderate | Generally favorable accountability record with a material ultimate-payer gap. |
Conclusion: Current audited statements, a single audit, and a public Form 990 are readily available; ultimate payer identity remains incomplete.
Support: FY2025 audited statements and single audit are posted by AAP. The FY2025 Form 990 was filed February 20, 2026. Accounting revenue categories reconcile to the audited total.
Contrary evidence / limitation: Donor identities, employer-paid dues, and a payer-class reconciliation are not publicly quantified.
Important unknown: The ultimate payer split within grants, dues, advertising, royalties, and other categories.
Conclusion: Not evaluable: public records do not provide a mutually exclusive ultimate-payer mix or top-funder concentration table.
Support: $23.18 million in FY2025 federal-award expenditures is documented. Corporate supporters are named in contribution tiers. Enterprise membership permits organization-paid invoices.
Contrary evidence / limitation: These indicators are nonadditive and do not identify the dominant payer class or top-one/top-three concentration.
Important unknown: Top-one and top-three funders, mutually exclusive payer classes, and sponsor-to-project amounts.
Conclusion: Spending, policy production, education, advocacy, and child-health programming substantially track the stated mission.
Support: $113.75 million was reported as program expense. $48.84 million was assigned to child-health activities. AAP describes a structured peer and board review process for policy.
Contrary evidence / limitation: Comprehensive independent outcome measures are not published for every major program.
Important unknown: Independent outcome measures for every major program and the effect of sponsored projects on priorities.
Conclusion: Defined physician-member categories vote and elect leaders, while the board appoints and supervises the CEO.
Support: Voting categories and board authority are stated in the bylaws. District and at-large directors are elected by members. The 2026 board and executive committee are publicly listed.
Contrary evidence / limitation: The publicly linked bylaws are dated 2020, and only 10.7% of eligible members voted in the 2025 election.
Important unknown: Whether a newer consolidated bylaw text exists, how board deliberations proceed, and participation by member segment.
Conclusion: AAP offers pathways for pediatric primary care, subspecialty, surgical, trainee, and other pediatric-team roles, but segment-level influence and outcomes are unevenly disclosed.
Support: Membership categories span career stages and pediatric disciplines. Specialty and surgical seats exist on the board. Payment advocacy explicitly includes primary care, medical subspecialists, and pediatric surgeons.
Contrary evidence / limitation: Governance participation, dues payer, and benefit outcomes are not broken down by physician segment; non-pediatric physicians are not the direct constituency.
Important unknown: Segment-level voting, dues-payer, participation, policy-win, and practice-outcome data.
Conclusion: Current leaders, senior operational roles, compensation, and conflict-management processes are substantially visible.
Support: Current board and senior leadership rosters are public. The Form 990 reports executive compensation. AAP publishes research conflict and policy-development procedures.
Contrary evidence / limitation: Aggregate conflict-management outcomes, board minutes, and sponsor-to-project firewall testing are not publicly detailed.
Important unknown: Aggregate recusals, conflict-management outcomes, board minutes, and project-level sponsor firewalls.
Confidence: Moderate. Sources: [4] [6] [7] [12] [13] [14] [15]
Conclusion: The FY2025 audits reported no material weaknesses or federal-program findings; one older DOJ settlement and significant pending 2026 litigation require context.
Support: The FY2025 single audit reported an unmodified opinion and no reportable findings. Pending cases are publicly traceable and are described as allegations or preliminary rulings, not final findings.
Contrary evidence / limitation: AAP paid a $22,000 civil penalty in a 2011 DOJ settlement over discriminatory job-posting restrictions; major 2026 cases remain unresolved.
Important unknown: Final outcomes of the 2026 cases and matters outside the targeted federal and public-docket search.
Conclusion: AAP publishes extensive policy, program, research, and financial information, but a unified independent outcomes dashboard was not found.
Support: Policy, research, educational, advocacy, and financial outputs are public. Programs and strategic initiatives are described with dates and accountable leaders.
Contrary evidence / limitation: Output volume does not by itself establish clinical or physician-practice impact.
Important unknown: A unified independently validated dashboard linking programs to child-health and physician-practice outcomes.
Publication status: Public review. A last-link check and final editorial approval are required before each release.
Organization review: The reviewed organization did not approve, edit, or veto the score. A factual correction process is described on the Blair Compass methodology and corrections pages.
Scope: Verification is limited to publicly accessible records. Private contracts, nonpublic minutes, sealed proceedings, and undisclosed conflicts are outside the available evidence.
Source rule: Primary and official records were preferred. Accounting categories were not converted into payer identities. Related entities were kept separate. Allegations were not treated as findings.
Verification: current leaders and major financial arithmetic were checked for this publication batch. Material corrections and future updates follow the published verification process.
